PMC:7293470 / 7695-7911 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7293470","sourcedb":"PMC","sourceid":"7293470","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7293470","text":"Drs. Vandenbark, Offner, Meza-Romero, and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology.","tracks":[{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T47","span":{"begin":0,"end":3},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0024265"},{"subj":"T47","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T101","span":{"begin":0,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0002819"},{"id":"T102","span":{"begin":52,"end":53},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T103","span":{"begin":123,"end":124},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T104","span":{"begin":147,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T101","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T102","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T103","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T104","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T45","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T45","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-MONDO","color":"#ecc293","default":true},{"id":"LitCovid-PD-CLO","color":"#a893ec"},{"id":"LitCovid-sentences","color":"#97ec93"}]}]}}